BioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.32, $0.08 better than the analyst estimate of $0.24. Revenue for the quarter came in at $91.7 million versus the consensus estimate of $88.3 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.